These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

504 related items for PubMed ID: 8158173

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Striatal opioid receptor binding in Parkinson's disease, striatonigral degeneration and Steele-Richardson-Olszewski syndrome, A [11C]diprenorphine PET study.
    Burn DJ, Rinne JO, Quinn NP, Lees AJ, Marsden CD, Brooks DJ.
    Brain; 1995 Aug; 118 ( Pt 4)():951-8. PubMed ID: 7655890
    [Abstract] [Full Text] [Related]

  • 3. Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
    Brooks DJ, Ibanez V, Sawle GV, Quinn N, Lees AJ, Mathias CJ, Bannister R, Marsden CD, Frackowiak RS.
    Ann Neurol; 1990 Oct; 28(4):547-55. PubMed ID: 2132742
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease.
    Antonini A, Leenders KL, Vontobel P, Maguire RP, Missimer J, Psylla M, Günther I.
    Brain; 1997 Dec; 120 ( Pt 12)():2187-95. PubMed ID: 9448574
    [Abstract] [Full Text] [Related]

  • 6. [Clinical utility of (18)F-DOPA-PET in movement disorders. A systematic review].
    Puñal-Riobóo J, Serena-Puig A, Varela-Lema L, Alvarez-Páez AM, Ruano-Ravina A.
    Rev Esp Med Nucl; 2009 Dec; 28(3):106-13. PubMed ID: 19558950
    [Abstract] [Full Text] [Related]

  • 7. Separating Parkinson's disease from normality. Discriminant function analysis of fluorodopa F 18 positron emission tomography data.
    Sawle GV, Playford ED, Burn DJ, Cunningham VJ, Brooks DJ.
    Arch Neurol; 1994 Mar; 51(3):237-43. PubMed ID: 8129633
    [Abstract] [Full Text] [Related]

  • 8. Striatal blood flow, glucose metabolism and 18F-dopa uptake: difference in Parkinson's disease and atypical parkinsonism.
    Otsuka M, Ichiya Y, Hosokawa S, Kuwabara Y, Tahara T, Fukumura T, Kato M, Masuda K, Goto I.
    J Neurol Neurosurg Psychiatry; 1991 Oct; 54(10):898-904. PubMed ID: 1744644
    [Abstract] [Full Text] [Related]

  • 9. Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease.
    Antonini A, Vontobel P, Psylla M, Günther I, Maguire PR, Missimer J, Leenders KL.
    Arch Neurol; 1995 Dec; 52(12):1183-90. PubMed ID: 7492293
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Regional striatal DOPA transport and decarboxylase activity in Parkinson's disease.
    Kuwabara H, Cumming P, Yasuhara Y, Léger GC, Guttman M, Diksic M, Evans AC, Gjedde A.
    J Nucl Med; 1995 Jul; 36(7):1226-31. PubMed ID: 7790948
    [Abstract] [Full Text] [Related]

  • 13. Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy.
    Oh M, Kim JS, Kim JY, Shin KH, Park SH, Kim HO, Moon DH, Oh SJ, Chung SJ, Lee CS.
    J Nucl Med; 2012 Mar; 53(3):399-406. PubMed ID: 22323779
    [Abstract] [Full Text] [Related]

  • 14. Some specific clinical features differentiate multiple system atrophy (striatonigral variety) from Parkinson's disease.
    Colosimo C, Albanese A, Hughes AJ, de Bruin VM, Lees AJ.
    Arch Neurol; 1995 Mar; 52(3):294-8. PubMed ID: 7872884
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Differentiating between multiple system atrophy and Parkinson's disease by positron emission tomography with 18F-dopa and 18F-FDG.
    Otsuka M, Kuwabara Y, Ichiya Y, Hosokawa S, Sasaki M, Yoshida T, Fukumura T, Kato M, Masuda K.
    Ann Nucl Med; 1997 Aug; 11(3):251-7. PubMed ID: 9310175
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Onset pattern of nigrostriatal denervation in early Parkinson's disease.
    Pineda-Pardo JA, Sánchez-Ferro Á, Monje MHG, Pavese N, Obeso JA.
    Brain; 2022 Apr 29; 145(3):1018-1028. PubMed ID: 35349639
    [Abstract] [Full Text] [Related]

  • 19. Striatal and extrastriatal dysfunction in Parkinson's disease with dementia: a 6-[18F]fluoro-L-dopa PET study.
    Ito K, Nagano-Saito A, Kato T, Arahata Y, Nakamura A, Kawasumi Y, Hatano K, Abe Y, Yamada T, Kachi T, Brooks DJ.
    Brain; 2002 Jun 29; 125(Pt 6):1358-65. PubMed ID: 12023324
    [Abstract] [Full Text] [Related]

  • 20. Striatal subregional 6-[18F]fluoro-L-dopa uptake in early Parkinson's disease: a two-year follow-up study.
    Brück A, Aalto S, Nurmi E, Vahlberg T, Bergman J, Rinne JO.
    Mov Disord; 2006 Jul 29; 21(7):958-63. PubMed ID: 16550545
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.